Sanqi Tongshu Capsules

Pharmacological tests have shown that this product has a significant protective effect on experimental cerebral ischemia and cerebral infarction animals, and can significantly improve their functional and behavioral disorders. It reduces cerebral vascular resistance and increases blood flow in the internal carotid artery of dogs. It can inhibit the aggregation of rat platelets induced by ADP, AA, and collagen, as well as the aggregation of human platelets induced by ADP, AA, PAF, and thrombin. At the same time, it can reduce the viscosity and hematocrit of rat whole blood and inhibit thrombosis. It also has the effect of improving microcirculation.

Notoginsenotriol saponin

This product is an enteric-coated capsule, the contents of which are light brown powder; odorless and bitter.

Oral administration. One tablet at a time, 3 times a day, 4 weeks as a course of treatment.

Some patients may experience nausea after taking the medicine

Pregnant women should not use it. Postpartum women should use it with caution. Cerebral hemorrhage is prohibited.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Keep in a sealed, dark, cool and dry place.

Each tablet contains 0.2g

2 years

Chengdu Huashen Technology Group Co., Ltd. Pharmaceutical Factory

• Founded in:

  2001-09-17

• Address:

  No. 3, Section 2, Jinhua Road, Southwest Airlines Economic Development Zone, Chengdu

• Tax NO.:

  915101227323530630

• Registered Funds:

  -

• Website:

  Log in to view

• Email:

  Log in to view